These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31677454)

  • 21. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
    Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
    J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
    de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
    Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
    Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
    Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH; Nagib N; Guthrie T
    Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
    Rousseau V; Morelle M; Arriuberge C; Darnis S; Chabaud S; Launay V; Thouvenin S; Roumenoff-Turcant F; Metzger S; Tourniaire B; Marec-Berard P
    Pain Pract; 2018 Jul; 18(6):788-797. PubMed ID: 29266772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011808. PubMed ID: 35802341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis.
    Friedman E; Minniti C; Campbell S; Curtis S
    Hematology; 2022 Dec; 27(1):742-744. PubMed ID: 35724398
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
    Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
    Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Pain; 2003 Mar; 102(1-2):187-93. PubMed ID: 12620610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
    Vosse D; Landewé R; Garnero P; van der Heijde D; van der Linden S; Geusens P
    Rheumatology (Oxford); 2008 Aug; 47(8):1219-22. PubMed ID: 18539620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium for treating sickle cell disease.
    Than NN; Soe HHK; Palaniappan SK; Abas AB; De Franceschi L
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011358. PubMed ID: 31498421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
    Taga M; Shirashu K; Minaguchi H
    Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary investigation of urine N-telopeptide concentration as a biomarker of bone resorption in dogs receiving glucocorticoids.
    Adamany JL; Cross GF; Gardner D; Dunning MD
    J Small Anim Pract; 2017 Jul; 58(7):403-407. PubMed ID: 28466603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual causes of abdominal pain: sickle cell anemia.
    Ahmed S; Shahid RK; Russo LA
    Best Pract Res Clin Gastroenterol; 2005 Apr; 19(2):297-310. PubMed ID: 15833695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.